Raw data. by Jia Zhu (135506)

“…Biomechanical results revealed that the ROM of the surgical segment had decreased significantly under six basic working conditions following NZ implantation. …”

Determinants of lipid lowering therapy intensification in very high risk patients with dyslipidaemia eligible for PCSK9 monoclonal antibodies: 1-year outcomes of the PERI-DYS study by Klaus G. Parhofer (12280424)

“…LDL cholesterol (LDL-C) changes and factors influencing lipid-lowering therapy (LLT) intensification were assessed after one year. …”

Clustering analysis of total and active RNAP II at genes during the transition from G1 to G2. by Douglas Maya-Miles (7024967)

(A) Cost-effectiveness plane in healthcare system perspectives; (B) Cost-effectiveness acceptability curve in healthcare system perspectives; (C) Cost-effectiveness plane in societ... by Jae-Heung Cho (798319)

Subjects:

Primary and secondary outcomes by treatment and time since randomization. by Jae-Heung Cho (798319)

Subjects:

Entomopathogenic fungi-derived copper nanoparticles (CuNPs) exhibited pupicidal activity against pupae of <i>A</i>. <i>albopictus</i> at 24 and 48h post treatment. by Perumal Vivekanandhan (4863484)

Subjects:

S1 Data - by Perumal Vivekanandhan (4863484)

Subjects:

Entomopathogenic fungi-derived copper nanoparticles (CuNPs) exhibited adulticidal activity against adult of <i>A</i>. <i>albopictus</i> at 24 and 48h post treatment. by Perumal Vivekanandhan (4863484)

Subjects:

Quality of life years after randomization into the <i>Chuna</i> manual therapy and usual care groups. by Jae-Heung Cho (798319)

Subjects:

The response of the <i>A</i>. <i>albopictus</i> larval Glutathione S-transferase (GST) enzyme increased 7.8-fold in response to <i>M</i>. <i>robertsii</i>-derived copper nanopartic... by Perumal Vivekanandhan (4863484)

Subjects:

Baseline characteristics of participants by randomized group. by Jae-Heung Cho (798319)

Subjects:

Schematic diagram of entomopathogen derived copper nanoparticles (CuNPs) and their toxic effects on target and non-target species. by Perumal Vivekanandhan (4863484)

Subjects:

Results of cost-effectiveness analysis of <i>Chuna</i> manual therapy compared with usual care^a. by Jae-Heung Cho (798319)

Subjects:

Entomopathogenic fungi-derived copper nanoparticles (CuNPs) exhibited larvicidal activity against larvae of <i>A</i>. <i>albopictu</i> at 24 and 48h post treatment. by Perumal Vivekanandhan (4863484)

Subjects:

Entomopathogenic fungi-derived copper nanoparticles (CuNPs) exhibited minimal toxicity effects against <i>E</i>. <i>eugeniae</i> at 24 and 48h post treatment. by Perumal Vivekanandhan (4863484)

Subjects:

Entomopathogenic fungi-derived copper nanoparticles (CuNPs) exhibited minimal toxicity effects against <i>A</i>. <i>salina</i> at 24 and 48h post treatment. by Perumal Vivekanandhan (4863484)

Subjects:

Table 2_Predicting ventilator-associated lower respiratory tract infection outcomes using sequencing-based early microbiological response: a proof-of-concept prospective study.docx by Ji Zhou (481629)

“…Objectives<p>Ventilator-associated lower respiratory tract infections (VA-LRTIs) cause significant mortality. …”

Image 1_Predicting ventilator-associated lower respiratory tract infection outcomes using sequencing-based early microbiological response: a proof-of-concept prospective study.tif by Ji Zhou (481629)

“…Objectives<p>Ventilator-associated lower respiratory tract infections (VA-LRTIs) cause significant mortality. …”

Table 3_Predicting ventilator-associated lower respiratory tract infection outcomes using sequencing-based early microbiological response: a proof-of-concept prospective study.docx by Ji Zhou (481629)

“…Objectives<p>Ventilator-associated lower respiratory tract infections (VA-LRTIs) cause significant mortality. …”

Table 1_Predicting ventilator-associated lower respiratory tract infection outcomes using sequencing-based early microbiological response: a proof-of-concept prospective study.doc by Ji Zhou (481629)

“…Objectives<p>Ventilator-associated lower respiratory tract infections (VA-LRTIs) cause significant mortality. …”